Related Experiment Videos
Traumatic optic neuropathy
1Orbital and Ophthalmic Plastic Surgery Division, Jules Stein Eye Institute, UCLA School of Medicine.
Survey of Ophthalmology
|May 1, 1994
Summary
Traumatic optic neuropathy knowledge is limited. Corticosteroid treatment success in spinal cord injury may not apply to optic nerve injury, requiring urgent intervention if effective.
Area of Science:
- Neuroscience
- Ophthalmology
- Trauma Surgery
Background:
- Pathophysiology of traumatic optic neuropathy (TON) is poorly understood.
- Optic nerve shares similarities with central nervous system white matter tracts.
- Corticosteroids, like methylprednisolone, possess antioxidant properties relevant to trauma.
Purpose of the Study:
- To explore potential pathophysiologic mechanisms of TON.
- To evaluate the applicability of National Acute Spinal Cord Injury Study 2 (NASCIS 2) findings to TON.
- To emphasize the need for accurate diagnosis and prompt management of TON.
Main Methods:
- Review of existing literature on CNS trauma and optic nerve pathophysiology.
- Analysis of corticosteroid pharmacology and its potential role in TON.
- Discussion of diagnostic approaches including clinical assessment and neuroimaging.
Main Results:
- Limited data exists on TON pathophysiology, drawing parallels with brain and spinal cord injury.
- The efficacy of methylprednisolone in NASCIS 2 may not directly translate to TON.
- Current medical and surgical treatments for TON lack proven superiority over no treatment.
Conclusions:
- TON management requires accurate diagnosis and comprehensive assessment.
- If corticosteroid treatment is effective for TON, NASCIS 2 suggests a critical treatment window of within eight hours.
- Ophthalmologists are urged to participate in collaborative research to address uncertainties in TON treatment.